Strata Critical Q2 adjusted EBITDA rises to $7.9 million; revenue increases 7% year-on-year to $72.5 million

Reuters2026/08/04 11:09

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Strata Critical posted Q2 2026 revenue of $72.5 million, reporting 7% organic year-on-year growth.
Adjusted EBITDA (non-GAAP) was $7.9 million.
2026 revenue outlook of $285 million-$295 million, with adjusted EBITDA (non-GAAP) forecast at $33 million-$35 million.
Business mix skewed to transplant-related work at about 84% of Q2 2026 revenue.
Network scale highlighted at 35+ owned and dedicated aircraft, 11 ground hubs, 55+ vehicles, and more than 90,000 missions completed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Strata Critical Medical Inc. published the original content used to generate this news brief on August 04, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Recently, Meta launched its personal AI agent product, Muse AI, marking the transition of consumer artificial intelligence from Q&A-based chatbots to an era of intelligent agents capable of independently completing real-world tasks. Goldman Sachs released a research report maintaining a “Buy” rating on Meta.

智通财经•2026/09/14 07:16